504 related articles for article (PubMed ID: 25645891)
21. Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.
Nolan RC; Galetta SL; Frohman TC; Frohman EM; Calabresi PA; Castrillo-Viguera C; Cadavid D; Balcer LJ
J Neuroophthalmol; 2018 Dec; 38(4):451-458. PubMed ID: 29384802
[TBL] [Abstract][Full Text] [Related]
22. Retinal nerve fiber layer thickness, brain atrophy, and disability in multiple sclerosis patients.
Abalo-Lojo JM; Limeres CC; Gómez MA; Baleato-González S; Cadarso-Suárez C; Capeáns-Tomé C; Gonzalez F
J Neuroophthalmol; 2014 Mar; 34(1):23-8. PubMed ID: 24162258
[TBL] [Abstract][Full Text] [Related]
23. OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients.
Khalil DH; Said MM; Abdelhakim MASE; Labeeb DM
Ocul Immunol Inflamm; 2017 Jun; 25(3):315-322. PubMed ID: 27070049
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients.
Garcia-Martin E; Pueyo V; Almarcegui C; Martin J; Ara JR; Sancho E; Pablo LE; Dolz I; Fernandez J
Br J Ophthalmol; 2011 Nov; 95(11):1577-82. PubMed ID: 21785155
[TBL] [Abstract][Full Text] [Related]
25. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
Frohman EM; Dwyer MG; Frohman T; Cox JL; Salter A; Greenberg BM; Hussein S; Conger A; Calabresi P; Balcer LJ; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):96-105. PubMed ID: 19439327
[TBL] [Abstract][Full Text] [Related]
26. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy.
Trip SA; Schlottmann PG; Jones SJ; Li WY; Garway-Heath DF; Thompson AJ; Plant GT; Miller DH
Neuroimage; 2006 May; 31(1):286-93. PubMed ID: 16446103
[TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.
Naismith RT; Tutlam NT; Xu J; Shepherd JB; Klawiter EC; Song SK; Cross AH
Neurology; 2009 Jul; 73(1):46-52. PubMed ID: 19564583
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
Sepulcre J; Murie-Fernandez M; Salinas-Alaman A; García-Layana A; Bejarano B; Villoslada P
Neurology; 2007 May; 68(18):1488-94. PubMed ID: 17470751
[TBL] [Abstract][Full Text] [Related]
29. Progressive degeneration of the retinal nerve fiber layer in patients with multiple sclerosis.
Herrero R; Garcia-Martin E; Almarcegui C; Ara JR; Rodriguez-Mena D; Martin J; Otin S; Satue M; Pablo LE; Fernandez FJ
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8344-9. PubMed ID: 23154461
[TBL] [Abstract][Full Text] [Related]
30. Diffusion tensor imaging correlates of visual impairment in multiple sclerosis and chronic optic neuritis.
Kolbe SC; Marriott M; Walt Av; Fielding J; Klistorner A; Mitchell PJ; Butzkueven H; Kilpatrick TJ; Egan GF
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):825-32. PubMed ID: 22247457
[TBL] [Abstract][Full Text] [Related]
31. RNFL thickness in MS-associated acute optic neuritis using SD-OCT: critical interpretation and limitations.
Serbecic N; Beutelspacher SC; Geitzenauer W; Kircher K; Lassmann H; Reitner A; Khan A; Schmidt-Erfurth U
Acta Ophthalmol; 2011 Aug; 89(5):e451-60. PubMed ID: 21401908
[TBL] [Abstract][Full Text] [Related]
32. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography.
Fjeldstad C; Bemben M; Pardo G
J Clin Neurosci; 2011 Nov; 18(11):1469-72. PubMed ID: 21917458
[TBL] [Abstract][Full Text] [Related]
33. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.
Longbrake EE; Lancia S; Tutlam N; Trinkaus K; Naismith RT
Mult Scler Relat Disord; 2016 Nov; 10():198-203. PubMed ID: 27919490
[TBL] [Abstract][Full Text] [Related]
34. OCT and VEP correlate to disability in secondary progressive multiple sclerosis.
Eklund A; Huang-Link Y; Kovácsovics B; Dahle C; Vrethem M; Lind J
Mult Scler Relat Disord; 2022 Dec; 68():104255. PubMed ID: 36544315
[TBL] [Abstract][Full Text] [Related]
35. Posterior segment spectral domain oct in the differential diagnosis of bilateral temporal optic neuropathy and its correlation with visual acuity.
Buelens T; Fils JF; Willermain F
Int Ophthalmol; 2022 Dec; 42(12):3877-3889. PubMed ID: 35809163
[TBL] [Abstract][Full Text] [Related]
36. Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis.
Watson GM; Keltner JL; Chin EK; Harvey D; Nguyen A; Park SS
J Neuroophthalmol; 2011 Jun; 31(2):110-6. PubMed ID: 21131852
[TBL] [Abstract][Full Text] [Related]
37. Optical coherence tomography and disease subtype in multiple sclerosis.
Pulicken M; Gordon-Lipkin E; Balcer LJ; Frohman E; Cutter G; Calabresi PA
Neurology; 2007 Nov; 69(22):2085-92. PubMed ID: 18040015
[TBL] [Abstract][Full Text] [Related]
38. Fourier-domain OCT in multiple sclerosis patients: reproducibility and ability to detect retinal nerve fiber layer atrophy.
Garcia-Martin E; Pueyo V; Pinilla I; Ara JR; Martin J; Fernandez J
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4124-31. PubMed ID: 21436273
[TBL] [Abstract][Full Text] [Related]
39. [Atrophy of the retinal nerve fibre layer in multiple sclerosis patients. Prospective study with two years follow-up].
García-Martín E; Pueyo V; Fernández J; Almárcegui C; Dolz I; Martín J; Ara JR; Honrubia FM
Arch Soc Esp Oftalmol; 2010 May; 85(5):179-86. PubMed ID: 23010522
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials.
Thurtell MJ; Bala E; Yaniglos SS; Rucker JC; Peachey NS; Leigh RJ
Neurology; 2009 Dec; 73(22):1849-57. PubMed ID: 19949031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
